Operating Expenses

Defined Contribution Plan Expense

Vertex Pharmaceuticals Defined Contribution Plan Expense remained flat by 0.0% to $15.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $13.08M to $15.78M. Over 2 years (FY 2023 to FY 2025), Defined Contribution Plan Expense shows an upward trend with a 20.3% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

An increase generally correlates with higher headcount or improved benefit packages, while a decrease may signal cost-cutting or reduced matching.

Detailed definition

The total cost recognized by the company for contributions made to employee defined contribution plans, such as 401(k) m...

Peer comparison

Standard operating expense for all large-scale employers; usually scales with total payroll.

Metric ID: msft_defined_contribution_plan_expense

Historical Data

3 years
 FY'23FY'24FY'25
Value$43.60M$52.30M$63.10M
YoY Change+20.0%+20.7%
Range$43.60M$63.10M
CAGR+20.3%
Avg YoY Growth+20.3%
Median YoY Growth+20.3%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's defined contribution plan expense?
Vertex Pharmaceuticals (VRTX) reported defined contribution plan expense of $15.78M in Q4 2025.
How has Vertex Pharmaceuticals's defined contribution plan expense changed year-over-year?
Vertex Pharmaceuticals's defined contribution plan expense increased by 20.7% year-over-year, from $13.08M to $15.78M.
What is the long-term trend for Vertex Pharmaceuticals's defined contribution plan expense?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's defined contribution plan expense has grown at a 20.3% compound annual growth rate (CAGR), from $43.60M to $63.10M.
What does defined contribution plan expense mean?
The cost of company contributions to employee retirement savings plans.